<?xml version="1.0" encoding="UTF-8"?>
<p id="Par29">Opioid abuse by itself can result in demyelination, leukoencephalopathy, and lesions in white matter (Offiah and Hall 
 <xref ref-type="bibr" rid="CR375">2008</xref>; Eran and Barak 
 <xref ref-type="bibr" rid="CR141">2009</xref>; Morales Odia et al. 
 <xref ref-type="bibr" rid="CR345">2010</xref>; Bora et al. 
 <xref ref-type="bibr" rid="CR52">2012</xref>; Li et al. 
 <xref ref-type="bibr" rid="CR283">2013</xref>), and the degree of myelin disruption correlates with the duration of opiate dependence (Ivers et al. 
 <xref ref-type="bibr" rid="CR221">2018</xref>). Chronic oxycodone exposure in rats causes some axonopathies and reduces the size of axonal fascicles, decreases myelin basic protein levels, and causes the accumulation of amyloid-Î² precursor protein (APP) (Fan et al. 
 <xref ref-type="bibr" rid="CR151">2018</xref>). Most preclinical studies have examined the effects of opioids and opioid receptor blockade on OL maturation and/or the timing of myelination (Hauser et al. 
 <xref ref-type="bibr" rid="CR204">1993</xref>; Knapp et al. 
 <xref ref-type="bibr" rid="CR241">1998</xref>; Stiene-Martin et al. 
 <xref ref-type="bibr" rid="CR487">2001</xref>; Sanchez et al. 
 <xref ref-type="bibr" rid="CR451">2008</xref>; Knapp et al. 
 <xref ref-type="bibr" rid="CR243">2009</xref>; Vestal-Laborde et al. 
 <xref ref-type="bibr" rid="CR526">2014</xref>). OLs can transiently express MORs and other opioid receptor types (Knapp et al. 
 <xref ref-type="bibr" rid="CR241">1998</xref>; Tryoen-Toth et al. 
 <xref ref-type="bibr" rid="CR512">2000</xref>; Knapp et al. 
 <xref ref-type="bibr" rid="CR242">2001</xref>; Stiene-Martin et al. 
 <xref ref-type="bibr" rid="CR487">2001</xref>). Selective MOR and possibly KOR activation can directly modulate the growth of OLs in vitro (Knapp and Hauser 
 <xref ref-type="bibr" rid="CR240">1996</xref>; Knapp et al. 
 <xref ref-type="bibr" rid="CR241">1998</xref>, 
 <xref ref-type="bibr" rid="CR242">2001</xref>).
</p>
